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Abstract
The creation of single-nucleotide polymorphism (SNP) databases (such as NCBI dbSNP) has
facilitated scientific research in many fields. SNP discovery and detection has improved to the
extent that there are over 17 million human reference (rs) SNPs reported to date (Build 129 of
dbSNP). SNP databases are unfortunately not always complete and/or accurate. In fact, half of the
reported SNPs are still only candidate SNPs and are not validated in a population. We describe the
identification of SNDs (Single Nucleotide Differences) in humans, that may contaminate the
dbSNP database. These SNDs, reported as real SNPs in the database, do not exist as such, but are
merely artifacts due to the presence of a paralogue (highly similar duplicated) sequence in the
genome. Using sequencing we showed how SNDs could originate in two paralogous genes and
evaluated samples from a population of 100 individuals for the presence/absence of SNPs.
Moreover using bioinformatics, we predicted as many as 8.32% of the biallelic, coding SNPs in
the dbSNP database to be SNDs. Our identification of SNDs in the database will allow researchers
to not only select truly informative SNPs for association studies, but also aid in determining
accurate SNP genotypes and haplotypes.
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Introduction
Single-nucleotide polymorphisms (SNPs) are the most common genetic variations in
humans and occur approximately once in every 100 to 300 base pairs
(http://www.ornl.gov/sci/techresources/Human_Genome/faq/snps.shtml and
http://www.maik.ru/abstract/biophyss/3/biophyss0081_abstract.pdf). The importance of
SNPs and haplotypes - composed of multiple SNPs statistically associated - has been
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documented in many complex disease association studies. SNPs are genetic markers likely
to cause phenotypic differences between individuals (Suh et al., 2005; Sachidanandam et al.,
2001). Therefore, SNPs, as well as haplotypes, are the genetic markers of choice in genome-
wide association studies (GWAS) (Kruglyak, 2008). The creation of SNP databases (such as
dbSNP at the National Center for Biotechnology Information [NCBI]) has facilitated
scientific research by providing useful information for complex disease association studies.
Although SNP discovery and detection in the last several years has improved to the extent
that the NCBI dbSNP database (Sherry et al., 2001) reports 17,103,982 reference SNPs (rs)
for Homo sapiens to date (October 28, 2008, Build 129), which accounts for 83% of all
20,569,318 sequence variations, only 63% are validated in populations
(http://www.ncbi.nlm.nih.gov/SNP/snp_summary.cgi). Previous studies (Mitchell et al.
2004) have highlighted that dbSNP has a false positive rate of approximately 15–17% due to
sequencing errors arising from base calling software. Therefore, there is a tremendous need
for objective evaluation of the online SNP databases (Reich et al., 2003).
In this report, we provide further experimental and computational evidence that not all SNPs
listed in the NCBI database are reliable. In fact, we show that as many as 8.32% of the
biallelic, coding SNPs in the NCBI dbSNP database appear to be artifacts due to the
presence of highly similar genes in the human genome. This kind of problem arises when
the DNA sequence similarity between two or more genomic regions is greater than 90%, i.e.
duplicons (Gut and Lathrop, 2004). Since many human genes derive from ancient
duplication (Britten, 2006), we believe a substantial portion of the SNPs, reported in the
SNP-GeneView page of the NCBI dbSNP, may not be real inter-individual DNA sequence
variations, but rather are sequence variations between two paralogous (i.e., highly similar
duplicated sequences) genes (Fredman et al., 2004) (Fig. 1).
We propose the term SND for Single Nucleotide Difference in a parallel to SNPs for these
artifactual polymorphisms present in the NCBI dbSNP database due to paralogue loci and
identify them using bioinformatics and experimental methods as well (Fig. 1).
Material and Methods
Bioinformatic procedure for the identification of SNDs
Preparation of genomic and SNP data—All 24 assembled chromosomes were
downloaded from the NCBI Genome FTP site (Build 36, Version 3; Release date: March 24,
2008; current release at September 22, 2008) and formatted into a BLAST database. The rs
SNP sequences associated with each of the 24 chromosomes were downloaded from the
NCBI dbSNP FTP site along with the chromosome report files on September 22, 2008
(Build 129 of NCBI dbSNP; Release date: April 14, 2008). Each SNP sequence contains a
header line with information about the SNP plus a variable length of sequence both up- and
down-stream from the actual SNP location. The Ensembl BioMart tool was used to generate
a list of unique coding SNPs drawn from dbSNP.
The SNP data was parsed to identify biallelic SNPs on the basis of the allele information in
the header line of each sequence. Comparison of rs numbers with the list obtained from
BioMart allowed the identification of those biallelic SNPs located in coding regions. Using
these conditions, 119,932 SNPs were selected for analysis (Fig. 2).
As we expect no fundamental difference between coding and non-coding SNPs in terms of
their propensity to be SND or not, coding SNPs were chosen as a convenient, representative
sample of the whole population of SNPs. This sample is of appropriate size to be tractable
with the computational resources available to the authors while being large enough to allow
generalization of the findings to all SNPs.
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Alignment of SNPs and identification of paralogues—Each SNP and its
surrounding sequence were aligned to the human genome using BLASTN (Altschul et al.,
1997). The genome was filtered for human repeats using Repbase (Jurka et al., 2005) and
also for low complexity sequence to eliminate spurious matches. An expectation threshold
of 0.001 was used to eliminate very short, but near identical spurious matches. The BLAST
output file for each sequence was parsed to determine the genomic locus or loci to which the
SNP could be mapped. Each high scoring pair (HSP) was considered and those alignments,
containing the SNP position, with sequence identity greater than 90% over at least 20% of
the full length of the SNP sequence, i.e., both left and right flanking sequences, were
selected as mapped loci. The parameters (90% identity and 20% sequence coverage) were
chosen as the maximum sequence identity and coverage possible to maximize sensitivity
and specificity of the bioinformatics technique, using the results of the experimental analysis
of 31 SNPs reported in the dbSNP. This was done by using, as a test set, the 31 SNPs from
AKR1C1 (aldo-keto reductase family 1 member C1, which used to be referred to DD1 as or
DDH1; MIM# 60049) and AKR1C2 genes (aldo-keto reductase family 1 member C1, also
known as DD2 or DDH2; MIM# 600450).
The two paralogous genes AKR1C1 and AKR1C2 are 97% similar, they are both located on
10p15-p14 in opposite transcriptional orientation. Their high sequence identity is probably
due to a recent gene duplication event. The AKR1C1 gene consists of 9 exons distributed
over a 15 kbp of genomic sequence, while the AKR1C2 gene has 11 exons distributed over
28 kbp. We used resequencing of 100 individuals as a validation method for the coding
SNPs reported in the NCBI SNP-gene page of the AKR1C1 and AKR1C2 genes and showed
that most of them are SNDs (Table 1).
The experimental determination of the status as SNDs or not of AKR1C1 and AKR1C2 genes
was accepted as correct. The bioinformatics analysis of these 31 SNPs was completed using
thresholds close to 100% for both sequence identity and coverage. False positives and false
negatives were manually examined and the thresholds were gradually reduced until
maximum specificity and sensitivity were obtained.
A small number of SNPs (146, 0.12% of the biallelic, coding SNPs) gave no BLAST results.
This was due to the length of the SNP region and the proportion of the SNP region filtered
by the two filters mentioned above. The remaining unfiltered region was insufficient to seed
a BLAST alignment. These SNPs were excluded from further analysis. A second group of
SNPs (117, 0.10% of the biallelic, coding SNPs) could not be mapped using this choice of
parameters.
For each mapping, the chromosome number, the direction of alignment of the SNP, the
genomic position of the SNP, and the allele at the position of the SNP were recorded. The
number of mappings for each SNP differs from the mapweight of SNPs provided by the
Chromosome Reports, which are also available on the dbSNP FTP site. These reports arise
from an attempt to specifically match each SNP to a single location on the genome as
described at: http://www.ncbi.nlm.nih.gov/books/bv.fcgi?rid=handbook.section.ch5.ch5-s8.
In this process, the real location of the SNP is distinguished from locations in paralogous
regions wherever possible. Thus as many SNPs as possible are mapped to only one location
(mapweight = 1) with higher mapweights (corresponding to 2 or more positions on the
genome) only being used when it is impossible to distinguish the true location from
paralogues. In contrast, our method seeks to identify and retain these paralogous regions as
well as the true SNP location, in order to assess the potential for paralogues to give rise to
SNDs.
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For SNPs with more than one genomic loci, both the set of alleles at the position of the SNP
and the base aligned to the actual SNP position in the rs record sequence were examined.
Where all aligned bases were the same as one of the two alleles listed in the rs record for the
SNP, the SNP was considered “real”. Where one or more of the aligned bases corresponded
to each of the two alleles listed in the rs record, the SNP was considered “SND. All other
cases where only one (or neither) of the two reported alleles was present along with other,
not reported alleles were classed as “undetermined” (Fig. 3).
For example, if the SNP is reported in dbSNP as a C/T variation and is mapped to two
genomic locations, then such SNP is classed as:
• real, if the aligned residue in both mapping loci is C or the aligned residue in both
mapping loci is T
• SND, if the aligned residue in one mapping locus is C while the corresponding
aligned residue in the second mapping locus is T
• undetermined, if the aligned residue in one mapping is C or T while the aligned
residue in the other mapping is A or G, or the aligned residue in both mapping loci
is A or G.
Classification of SNDs—The chromosome report files were parsed to extract the
heterozygosity and validation code associated with the SNP. The heterozygosity of each
SND with exactly 2 mapped genomic loci was examined. If the heterozygosity of the SNP
was over 0.4 and the validation code less than 4, the SND was classed as “very strong
SND”, indicating a higher likelihood the SNP is a SND. If the heterozygosity of the SNP
was over 0.4 and the validation code more than 4 the SND was classed as “strong SND”.
Identification of SNDs in AKR1C1 and AKR1C2 genes
Gene-specific primer design—AKR1C1 and AKR1C2 exons were amplified using
oligonucleotide primers designed from flanking intronic or untranslated sequences (Supp.
Table S1). For the design of PCR primers in the intron/exon boundaries, we used the
genomic sequence obtained from GenBank [National Center for Biotechnology Information
(NCBI)]. Usually the design of gene-specific primers (primers that anneal only to the target
gene) is a simple task achieved by blasting the primer against the whole genome database
(NCBI database). However, when dealing with genes that have been duplicated during
evolution, such as pseudogenes, tandem repeats and paralogues, then SNP assays must be
carefully designed to avoid mixed PCR products, resulting from the amplification of
different genomic regions. All the primers for AKR1C1 and AKR1C2 genes were designed in
regions where at least one mismatch (highlighted in red in Supp. Table S1) between the two
genes was present. Usually the mismatch was positioned at the 3′ end of the oligonucleotide.
The alignments between the two genes were performed using the sequence alignment
program ClustalW2 (http://www.ebi.ac.uk/Tools/clustalw2/index.html). Exon 1 of AKR1C1
aligned with exon 3 of AKR1C2.
PCR reaction optimization—Taq polymerase (Fermentas; USA) was used for all intron/
exon PCR reactions. Reactions were optimized individually with variations of annealing
temperatures and MgCl2 concentration to yield specific PCR products.
Fluorescence-based DNA sequencing of PCR amplicons—DNA sequencing was
carried out using an ABI 3730 automated sequencer and the ABI PRISM Dye Terminator
Cycle Sequencing Kit, V.3 (Applied Biosystems, Foster City, CA). PCR amplicons were
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purified using Marligen’s PCR purification kit (Marligen Bioscience Inc. Ijamsville, MD)
according to the manufacturer instructions, and sequenced with both forward and reverse
primers.
SNP discovery was performed by aligning the electropherogram of each individual using
both visual analysis and the demo version Sequencer software program (Gene Codes
Corporation, Ann Arbor, MI).
Results
We propose the term “Single Nucleotide Difference” or SND for these artifactual
polymorphisms (Fig. 1) and suggest that up to 8.32% of the biallelic coding SNPs in the
NCBI dbSNP database are likely to be SNDs (Table 2 and Supp. Table S2).
We used a comprehensive bioinformatic approach (Fig. 2 and Fig. 3) to identify potential
SNDs in the NCBI database (Build 129). The 14,319,123 reported SNPs were parsed to
select a total of 119,932 biallelic coding SNPs for SND analysis. The sequence surrounding
the SNP, as reported in the rs record of dbSNP, was used to align each SNP against the
human genome. Only those alignments including the SNP position with at least 90%
sequence identity (SID) over 20% of the full length of the SNP sequence or sequence
coverage (SC) were selected as mapped loci.
A small number of SNPs (0.22% of the biallelic, coding SNPs) could not be mapped to the
genome for reasons discussed in the Material and Methods section. SNPs producing only
one alignment (82.12% of the biallelic, coding SNPs) with 90% SID and 20% SC were
considered correct SNPs since they could be mapped unambiguously to only one
chromosomal position. SNPs with two or more alignments (17.67% of the biallelic, coding
SNPs) were considered to be potential SNDs and examined further.
Of the 21,184 SNPs, aligning with multiple loci, 9,979 were SNDs, 10,357 correct SNPs,
and 848 undetermined SNPs (Fig. 3). In total, 9,979 SNPs were determined to be SNDs
(8.32% of the biallelic, coding SNPs), 108,842 SNPs were determined to be accurate
(90.75%), and the remainder 1,111 SNPs were undetermined (0.93%).
The SNDs were examined further for additional evidence by comparison with
heterozygosity (H) data. In particular, when the heterozygosity value of the SNP is between
0.4 and 0.5, then the SNP is more likely to be a SND. In fact, in many SNP discovery
procedures the co-amplification by polymerase chain reaction (PCR) of two paralogous
genes can be misinterpreted as a SNP with H>0.4. In our analysis there were 3,121 SNDs
with exactly two genomic mappings; of these 456 (14.61%) had heterozygosity scores in
excess of 0.4. We further classified these 456 SNPs into two groups depending on the
validation code associated with the SNP (Table 2 and Supp. Table S2). The first group of
189 SNDs are classified as “very strong SNDs” as they have validation code <4, while the
second group of 267 SNDs are “strong SNDs” with validation code >4. A lower validation
code indicates less evidence for the existence of the SNP and validation code 4 indicates that
at least one of the cluster of submitted SNPs (ssSNPs) associated with the reference SNP
(rsSNP) has been experimentally validated.
The list in Table 1 includes all the reported SNPs in the NCBI database for AKR1C1 and
AKR1C2 genes. We classified as SNDs all the SNPs reported in the SNP database that could
not be found in a population of 100 non-related individuals and that had as variant allele the
same nucleotide as the contig of the paralogue in the corresponding position (i.e. a SND
corresponds to a mismatch in the alignment of the two genes). Of the 31 SNPs
experimentally analyzed, we found 22 to be SNDs and 9 non-SNDs (Table 1).
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The experimental and bioinformatic analyses were compared using the 31 SNPs
experimentally analyzed (Table 1). If the experimental data above is used as a reference for
the classification of SNPs as SNDs, the bioinformatic predictions have a low false positive
rate (2 false positives among 9 experimentally confirmed non-SNDs) and a very low false
negative rate (1 false negative among 22 experimentally confirmed SNDs).
PCR amplifications of exons containing the SNPs reported in Table 1 were performed using
gene-specific primers (Supp. Table S1). PCR conditions used to produce gene-specific target
regions were obtained through optimization of PCR reactions. The parameters adjusted were
annealing temperature, MgCl2 concentration, number of cycles, and annealing time.
In general, specific amplification is complicated when the target gene has one or more
highly similar genes (paralogues) in the genome. Non-specific products, commonly known
as bias, are usually due to annealing of the primers to regions in the genome different from
the target. Promiscuous primers anneal non-specifically when their sequence has 100%
identity with two or more chromosomal locations and/or when PCR conditions are such to
favor non-specific primer annealing (e.g. high MgCl2 and low annealing temperatures). The
success of gene-specific amplification relies on primer design. In Fig. 4 we show how SNDs
could originate when designing non-specific or “promiscuous” primers (Supp. Table S1), i.e.
primers that do not discriminate between the two paralogous genes. In another experiment,
we used specific primers for the AKR1C1 gene and showed that even with good primer
design one could obtain co-amplification (mixed PCR products) if PCR conditions are sub-
optimal (Fig. 5).
In order to assess the potential practical implications of SNDs, we also examined the
presence of SNDs for Illumina and Affymetrix SNP submissions to NCBI. The list of SNPs
and their flanking sequence was downloaded from the dbSNP database. We found 35,785
SNPs from our set of biallelic coding SNPs on the Illumina array. Of these 582 were SNDs
(1.6%). Similarly, we found 8,647 SNPs from our set on the Affymetrix array and, of these,
215 (2.5%) were SNDs. There are thus real, practical implications associated with the
presence of SNDs in the database.
Moreover to identify specific examples of SNDs having been associated with disease, we
examined several potential sources of information associating SNPs with disease: Online
Mendelian Inheritance in Man (Amberger et al., 2009), the database of Genotypes and
Phenotypes (dbGaP, http://www.ncbi.nlm.nih.gov/sites/entrez?db=gap), MedRedSNP (Rhee
and Lee, 2009), the Office of Population Genetics (OPG) catalog of genome wide
association studies (Hindorff et al., 2009), and SNPedia (www.snpedia.com). Of these, only
the latter two provided information associating individual SNPs with disease in a format
suitable for automated analysis. The OPG catalog contains SNP-trait associations with p-
values < 1 × 10−5 drawn from PubMed literature searches and other sources. SNPedia
provides information on associations between SNPs and disease drawn from a range of
sources, including literature reports and manual extracts from other databases such as
OMIM.
Of the 6,344 SNPs available for download from SNPedia
(www.snpedia.com/files/gbrowse/snpedia) and the 1,979 SNPs available for download from
the OPG catalog, there were 6,486 unique SNPs, indicating a significant overlap between
the two sources of data. Of these 6,486 SNPs, 1,849 were among the biallelic, coding SNPs
examined in this study. Of these, 50 were SNDs and 1799 were not SNDs. Thus 0.5% of
SNPs identified as SNDs have a disease association in SNPedia compared with 1.7% of
those SNPs identified as not SNDs.
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The fifty SNDs were only found in the SNPedia database. Manual examination of the
SNPedia records for the fifty SNDs, showed 32 with either cross-references to OMIM or
direct references to the scientific literature for range of “disorders” varying from the benign
(e.g. blue eye color) to severe, highly prevalent disorders such as melanoma, schizophrenia,
age-related macular degeneration, and diabetes. Thus, even in this small set of disease-
associated SNPs, practical issues resulting from the presence of SNDs in the database do
occur.
Discussion
We have systematically investigated the SNP database (dbSNP at NCBI, Build 129) for
contamination by “Single Nucleotide Differences” or SNDs (as a parallel to SNPs) which
are artifacts due to the presence of a paralogue (highly similar duplicated) sequence in the
genome (Fig. 1).
The presence of such spurious SNDs in the database at a surprisingly high frequency of up
to 8.32% (Table 2) is a concern. We also provide experimental validation in two very similar
paralogues, AKR1C1 and AKR1C2, for SNDs. Fredman et al. (2004) previously reported the
presence of “complex SNP-related sequence variation in segmental genome duplications”.
We not only experimentally confirm their findings in duplicons, but extend the analysis to
whole-genome. Furthermore, we highlight the issue by proposing to name these recurrent
SNPs as SNDs (Single Nucleotide Differences) to aid further discussions of this
phenomenon. We think it is of fundamental importance to identify SNDs in paralogus genes,
since, as was previously reported by Yandell (2008), the probability of finding disease-
related SNPs is higher in paralogous genes.
We propose that SNDs may have found their way into the online SNP database by at least
two distinct ways: 1. by uncritical bioinformatic alignments, e.g. BLAST, of highly similar
but distinct DNA sequences and 2. by PCRs using “promiscous” primers that do not
discriminate properly between very similar yet different DNA segments. Thus, investigators
are encouraged to use appropriately stringent methods when identifying, submitting and
validating SNPs.
The validation code in the SNP record provides some limited information on how the SNP
was identified and on the experimental evidence confirming its existence. The validation
code is a number from 0 to 31 indicating an increasing level of experimental evidence for
the SNP, broadly divided into 6 validation methods (none, by cluster, by frequency, by
submitter, by double hit, and by HapMap). If the SNPs are grouped according to their
validation method, the percentage of SNDs in each group is higher than the overall SND
percentage in most groups. It rises from 9% in the “by frequency” group to 34% in the “by
submitter” group. Only the HapMap validation method shows a reduced prevalence of
SNDs, with only 3% of the 49,261 SNPs in this group being SNDs. Thus, there is little
correlation of validation code with SND status. Furthermore, while restricting the use of
SNPs to those validated by HapMap will reduce the prevalence of SNDs, it comes at the cost
of ignoring 56% of the real SNPs in the database whose validation code falls into one of the
other categories.
Another potential method for eliminating SNDs is to remove those SNPs associated with the
“Lee” submissions. Anecdotally, it has been assumed that many of these submissions to
dbSNP are false, although we were unable to identify a published study verifying this
assumption. However, as a number of the SNDs identified in AKR1C1 and AKR1C2 genes
are based on data from the “Lee” submissions, we decided to explore this possibility further.
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In order to do so, we searched dbSNP using the handle associated with the Lee submissions.
There are three such sets of submitted SNPs comprising a total of 99,992 submitted SNPs.
These correspond to 58,983 reference SNPs of which 10,344 were among the biallelic
coding SNPs examined in this study. Of these, 1,991 were SNDs and 8,353 were not SNDs.
Thus, 20% of the SNPs identified as being SNDs are Lee SNPs compared with 8% of those
SNPs identified as being not SNDs.
This indicates that, while a substantial proportion of the SNDs are due to the “Lee”
submissions, eliminating these will still leave 80% of the SNPs identified as being SNDs.
Further, eliminating the “Lee” submissions would also remove almost 10% of SNPs we
have identified as legitimate (not SND).
A manual examination of other non-structured text in the dbSNP records or the associated
biomedical literature may help to reveal the source of specific SNDs, but it is not feasible to
undertake such an analysis in a systematic way for all SNDs.
We note here that the presence of such SNDs in the database at a significant frequency of up
to 8.32% can create serious problems in SNP-based association studies of candidate genes
(Dvornyk et al., 2004) as well as in haplotype-based investigations (de Bakker et al., 2005).
The former may be affected as one is not really investigating a SNP at all, the latter as SNDs
would break haplotype blocks as well. One method of eliminating SNDs is through a careful
sifting of paralogous gene SNPs to determine their validity. A thorough “housecleaning” of
online SNP databases that will aid in the selection of correct SNPs and haplotype tag SNPs
(htSNPs) that allow accurate association and linkage data.
We believe SNDs may systematically bias association studies toward a false (probably
mostly negative) conclusion. Furthermore, if SNDs are used as tagSNPs they may disrupt
haplotype blocks as noted above and also affect association studies, although the extent of
this possibility will depend on a number of factors including the number of tagSNPs
involved. Thus, SNDs should be carefully considered and eliminated from any such studies.
Furthermore, there may also be clinical implications should SNDs be used as genomic
biomarkers in personalized medicine or drug development. Such studies should pay great
attention to choosing only legitimate SNPs, and regulatory submissions for diagnostic,
therapeutic, or preventative methods and technologies based on SNP data should be
thoroughly examined for the presence of erroneous SNPs.
In conclusion, significant efforts should be made toward purging such SNPs from all online
databases. SNPs in gene families with high frequencies (e.g. above 0.3), that are not in
Hardy-Weinberg equilibrium in association studies ought to be considered as “suspect” or
candidate SNDs. In the meantime, researchers, especially with negative association studies,
may wish to consider carefully whether they may have inadvertently genotyped SNDs.
Finally, we note that association results should be supported by functionally relevant data on
such genotyped SNPs and/or haplotypes to confirm that the results are truly causal
(Mehrian-Shai and Reichardt, 2004).
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The origin of “Single Nucleotide Differences” or SNDs in paralogous genes.
In panel A. gene 1 and gene 2 are highly similar paralogous genes, they differ in one or
more nucleotides. In this simple example, the two genes differ in two positions: position 1
and position 50. These positions refer to two residues occupying the corresponding positions
in both genes when the genes are aligned. Whenever the two genes are co-amplified because
of poor primer design or suboptimal PCR conditions, or whenever uncritical sequence
alignments are performed, the sequence of the mixed PCR product or the mismatch in the
alignment could be mistakenly interpreted as a SNP for gene 1, panel B, or as a SNP for
gene 2, panel C and therefore incorrectly reported in the database.
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Bioinformatic procedure for the identification of SNDs.
The chart diagram describes step-by-step the procedure used to identify SNDs in the NCBI
dbSNP database, Build 129. Only BLAST hits with 90% SID and 20% SC containing the
SNP were selected as mapped loci.
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Analysis of the 21,184 SNPs aligning with multiple mapping loci to determine the SND
status. The figure shows an example in which the sequence of the reported SNP (rs ID)
aligns to two mapped loci (Locus 1 and Locus 2) with at least 90% SID and 20% SC. The
reported SNP is Y (C/T). The left part of the figure (panels A and B) shows two mappings
resulting in the SNP being classed as “real”. The middle part (panels C and D) shows two
mappings resulting in the SNP being classed as “SND”. The right part (panels E and F)
shows two examples of mappings resulting in the SNP being classed as “undetermined”.
Other combinations are possible as well.
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SNDs in exon 2 of the AKR1C1 gene and exon 4 of the AKR1C2 gene.
The sequence in panel A and C was obtained using AKR1C2 and AKR1C1 specific primers,
respectively. The two sequences differ at nucleotide positions indicated with an asterisk in
panel B. The sequence in panel B was obtained using non-specific primers i.e. primers
amplifying both exon 2 and exon 4 of the two genes, producing a mixed PCR product.
We also show that AKR1C2 and AKR1C1 SNDs are located exactly where the mismatches
between the two genes are. These SNPs are included in Table 1.
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AKR1C1 and AKR1C2 co-amplification of exon 2 and exon 4 respectively in suboptimal
PCR conditions using AKR1C1 specific primers for AKR1C1 exon 2 (Supp. Table S1). Panel
A and B show electropherograms of mixed AKR1C1/AKR1C2-PCR products using sub-
optimal PCR conditions: 2.5mM MgCl2 and 54°C annealing temperature (A) and 2.5mM
MgCl2 and 58°C annealing temperature (B). On the other hand panel C shows the AKR1C1-
specific PCR product produced using 1.5mM MgCl2 and 61°C annealing temperature.
Thus, with decreasing MgCl2 concentration and increasing annealing temperature the double
peaks become less prominent (A and B) and even completely eliminated (C).
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Table 2
Summary of the SNPs analyzed using bioinformatics and those found to be SNDs
Number of SNPs % of SNPs
SNPs analyzed 119,932 100
SNDs 9,979 8.32
Strong SNDs 456 0.38
Very Strong SNDs 189 0.16
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